October 20, 2021
“Are stocks setting up for another decade of monstrous returns? Bank of America doesn’t think so. In fact, the banking giant’s valuation model is forecasting a flat return for the stock market over the next decade. Depressing, right? But here’s… Continue Reading…
January 6, 2021
“9 Meters Biopharma (NMTR)… Turning now to the rest of the Street, other analysts are on the same page. With 4 Buys and no Holds or Sells, the word on the Street is that NMTR is a Strong Buy. Given… Continue Reading…
November 27, 2020
“Undervalued Dividend Aristocrat #1: AbbViev… Our fair value estimate for AbbVie stock is a P/E of 10.5, compared with a forward P/E of 8.4. This means that if AbbVie’s valuation expanded from 8.4 to 10.5 over the next five years, total returns… Continue Reading…
Recent Comments